Cannabis, marijuana and Hemp stock news from Investorideas.com plus daily cannabis #potcasts - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSX: $BVO.V) (TSX: $TGOD.TO) (TSX: $TRST.TO) (CSE: $AGRA.C) (CSE: $BLOX.C) (CSE: $BGRD.C)
Delta, Kelowna, BC - January 8, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today, Zenabis Global Inc. announced the completion of the reverse takeover of Bevo Agro Inc. by Sun Pharm Investments Ltd. to create a company that has the potential to become one of the largest licensed marijuana companies in the world.
As previously announced on October 4, 2018, Bevo and Sun Pharm entered into an arrangement agreement with respect to the spin-out of Bevo's interest in CubicFarm Systems Corp. and subsequent a reverse take-over of Bevo by Sun Pharm, with the resulting combined issuer being Zenabis.
While the Spin-Out and RTO were effective on January 8, 2019, Bevo shares will continue to trade on the TSX-V until January 9th under the Bevo name but investors purchasing on the TSX-V on this trading day will no longer have an entitlement to participate in the Spin-Out and receive their pro rata percentage of CubicFarm Shares. On January 10th Bevo shares will no longer trade and Zenabis Shares will trade on the TSX-V under the Zenabis name and "ZENA" trading symbol
"The commencement of trading on the TSXV marks the achievement of yet another goal in a long line of important milestones for our company," said Monty Sikka, Chair of the Board of Directors for Zenabis. "We see our entry into the public marketplace as an incredible opportunity, and look forward to significantly growing shareholder value as we continue to execute on our expansion strategy. Our goal is not only to maintain our commitments to domestic sales partners, but for Zenabis to become the supplier of choice across a range of international markets. As countries around the world follow Canada's lead, allowing greater access to cannabis and related products, we intend to become a global leader in cannabis production and products."
The resulting entity, Zenabis, has the potential to become one of the largest cannabis producers based on available production space.
Through its subsidiary licensed producer Zenabis Ltd. and other subsidiaries expected to be licensed, Zenabis Global Inc. will have 3.5 million square feet of constructed premises available that it has already converted or intends to convert into cannabis production space.
The Green Organic Dutchman Holdings Ltd. announced that it has appointed Dr. Caroline MacCallum and Jacques Dessureault to its Board of Directors.
Dr. Caroline MacCallum is one of the world's most prominent experts in cannabinoid-based medicine. She is an internist, complex pain and cannabinoid clinician, researcher and clinical instructor in the Department of Medicine, an adjunct professor in the Faculty of Pharmaceutical Sciences Program and an associate member of the Department of Palliative Care at the University of British Columbia. She is also the medical director at Greenleaf Medical Clinic, where she has assessed and developed cannabinoid treatment plans for more than 3,000 patients across Canada.
Mr. Jacques Dessureault has had an extensive pharmaceutical career including significant experience in life sciences, over-the-counter, natural health, and technology industries.
"We are incredibly fortunate to add Dr. MacCallum and Jacques Dessureault to our Board of Directors at such a pivotal time, as we approach production ramp-up and our first commercial sales," commented Jeff Scott, Chairman of the Board. "The TGOD Board now consists of independent directors with the exception of our CEO. Both new additions possess valuable skills and extensive experience that will greatly benefit TGOD moving forward."
CannTrust Holdings Inc., one of Canada's leading, most trusted licensed producers of cannabis and the 2018 Canadian Cannabis Awards "Top Licensed Producer of the Year", announced that it has applied to list its common shares on the New York Stock Exchange.
Listing of the Company's common shares on the NYSE remains subject to the approval of the NYSE and the satisfaction of all applicable listing and regulatory requirements. In connection with the intended listing on the NYSE, the Company has filed a registration statement on Form 40-F with the United States Securities and Exchange Commission. The Registration Statement has not yet been declared effective by the SEC. Upon receipt of all required approvals and completion of the formal listing process, the Company will publicly announce its first trading date on the NYSE.
"CannTrust has firmly established itself as one of the top licensed producers in Canada with a global platform rooted in trust, science and innovation," said Peter Aceto, CEO of CannTrust. "A listing on the NYSE is a natural step forward in our evolution as we look to broaden our investor base, increase the Company's exposure and expand our business on an international scale."
AgraFlora Organics International Inc. (formerly PUF Ventures Inc.), a growth oriented and diversified international cannabis company, and Blox Labs Inc., announced a letter of intent to negotiate in good faith a definitive agreement whereby AgraFlora and BLOX intend to form a joint venture company to build a best-in-class team of professionals from the cannabis, agriculture and pharmaceutical sectors to manage and operate state-of-the-art agricultural greenhouse facilities.
Currently BLOX has executed a letter of intent with Best Cannabis Products Inc. (BCP) to enter into a definitive agreement to acquire a 180,000 sq. ft greenhouse facility on 50 acres of land in Leamington, Ontario.
"I am very pleased to announce the letter of intent with AgraFlora Organics to create a cannabis operations management company that would oversee future cannabis operations including our potential ownership in the Leamington, Ontario project," said Jeff Zanini, CEO and Director, Blox Labs Inc. "Derek has built an impressive management and operations team for AgraFlora and its large-scale greenhouse complex in Delta, BC and we will work together to do the same for the Leamington cannabis greenhouse and other projects. AgraFlora brings years of large-scale greenhouse experience to BLOX and the Leamington project and we will leverage this experience to introduce industry best practices to create the most efficient operation possible."
Braingrid Limited, a global provider of affordable, scalable and easy-to-deploy sensor platforms for precision agriculture announced the launchof its new self-powered "Sentroller S".
Sentroller S brings all the great features of Braingrid's original Sentroller platform to cultivators including a quick installation, online dashboards and reports, as well as email alarm notifications. This allows growers the peace of mind that their cannabis crops are safe and thriving.
The Sentroller S is powered by a solar panel that enables an even quicker install and limitless possibilities for sensor placement. This true wireless freedom helps cultivators monitor growing conditions where it matters - in and around the plant canopy where power connections are not often available. Any form of grow lighting including LED is sufficient to power the ultra-low energy Sentroller S.
The new self-powered Sentroller S differentiates Braingrid from the competition by monitoring mission critical cultivation parameters (i.e. temperature, relative humidity, CO2, PAR, EC, moisture) in the plant canopy, without power cords or the need to change batteries.
Michael Kadonoff, Founder and CEO of Braingrid, stated "The Sentroller S launch marks yet another important milestone for Braingrid that aligns with our strategic plan and continues our momentum that has been building since the launch of our original Sentroller as we strive to provide the best precision technology solution to the cannabis cultivation industry".
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
Investing in a New Age of #Cannabinoid Production for Cost Efficiency and Scalability: (OTCQB: $SING) (NASDAQ: $CRON) (OTC: $OGRMF) (NASDAQ: $XOM)
Latest trend gaining momentum in the market - advanced techniques in cannabis cultivation
Point Roberts, WA and Delta, BC - January 8, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot of companies investing in new methods of cannabinoid production to meet the growing demands of the future.
According to Research and Markets, "The legal cannabis market is projected to register a CAGR of over 27% by 2023 and the latest trend gaining momentum in the market is the use of advanced techniques in cannabis cultivation."
Leading the way, NASDAQ's first listed cannabis stock, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) and Ginkgo Bioworks, the organism company, in early September announced a partnership to produce cultured cannabinoids.
Cronos Group described the benefits of the deal in their presentation "Through biosynthesis Cronos Group and Ginkgo Bioworks are creating a landmark partnership that will reduce the cost of cannabinoid production, create commercial scale and the ability to access rare cannabinoids."
Continued: "Gingko Bioworks' platform could enable Cronos Group to produce the cannabinoids (ingredients) that are essential for product development at a fraction of the cost, at commercial scale and at higher purity than what is currently available."
One of the goals of the partnership, (estimated at $100M US with cash and stock and incentives) is to "Target production yields at a fraction of the cost of traditional cannabinoids production in plants: < $1,000 USD per KG."
Cronos Group will have the exclusive right to use and commercialize the key patented intellectual property related to the production of the target cannabinoids perpetually and globally.
Following similar mindset, SinglePoint, Inc. (OTCQB:SING), a company positioned in the sector with its subsidiary SingleSeed.com, an ecommerce-based business that sells and supplies industrial-based hemp cannabidiol (CBD) products, just announced its investment in TorusMed Inc. to develop CBD Cell Cultures from industrial hemp.
From the news: "The goal of the project is to ultimately have CBD that is pharmaceutical grade and cultivated in lab settings to ensure consistency. This project has the opportunity to change the way industrial hemp and CBD are manufactured reducing time, cost and valuable resources while increasing consistency, safety and scalability of the plant."
Continued: The specific aim of this is to develop the optimal protocols for the mass production of CBD from cell cultures of industrial hemp. The production of CBD from cell cultures is far more advantageous than from open-field farm cultivation of industry hemp for the following reasons: (1) independence from outside weather and seasonal climatic conditions; (2) environmentally-controlled production system in laboratory flasks and in scalable industrial photobioreactors; (3) optimal protocols for cell biomass growth and CBD production; (4) greater resource-use efficiency in terms of water, land nutrients, etc.; (5) greater convenience and efficiency in scale up of production in terms of using scalable industrial photobioreactors, among others. The specific objectives of the study include: (1) To develop and establish cell cultures of industrial hemp both in the form of callus cells and of liquid cell suspension cultures; (2) To optimize the biomass growth of the cell suspension cultures in terms of nutrient media, light intensity, light quality and carbon dioxide (CO2) enrichment; (3) To optimize the CBD yield of the cell suspension cultures in terms of nutrient media, light intensity, light quality, and carbon dioxide (CO2) enrichment; and (4) To demonstrate the cultivation of the cell suspension cultures in scalable Photobioreactor. The specific aim for a potential Year 2 for the study is to develop the protocols for the cultivation of the cell cultures and production of CBD in industrial-scale Photobioreactors.
In September, Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), a licensed producer of medical marijuana reported the closing of its strategic investment ($10 million Cnd) in Hyasynth Biologicals Inc., a biotechnology company based in Montreal and a leader in the field of cannabinoid science and biosynthesis.
From the news: "Hyasynth's patent-pending enzymes, yeast cells and processes make it possible to produce phytocannabinoids and phytocannabinoid analogues in genetically modified strains of yeast. Hyasynth's proprietary enzymes and yeast strains have to date allowed them to make CBG, CBD and other cannabinoids for novel and specialized products including vapourizable cannabis products and cannabis-infused beverages, as well as pharmaceutical ingredients, for a fraction of the cost of traditional plant-based production. The company will continue to develop a comprehensive platform of cannabinoids beyond THC, CBD and CBG for both medical and recreational use."
Another company looking at utilizing yeast for the production of cannabinoids, Intrexon Corporation (NASDAQ: XON) in September announced advances in the development of its microbial platform to produce cannabinoids for medical uses. "Through Intrexon's proprietary technologies, the Company has engineered a yeast strain to produce low-cost, robust and consistent cannabinoid outputs via fermentation. This process utilizing microbes has the potential to provide greater supply-chain security and avoids the resource-intensive isolation that often leads to quality and quantity variability in end products."
With yeast currently used in the making of beer and wine and the recent deal flow in the beer/cannabis and CBD beverage market, it seems like a natural next step for the cannabis industry to be researching how yeast can play a future role.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
This news is published on the Investorideas.com Newswire - News that Inspires big ideas
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring SING is a paid for news release on Investorideas.com. Learn more about costs and our services https://www.investorideas.com/News-Upload/
